China Biologic’s $1.1 Billion Loan

Ogier has acted as Cayman Islands counsel to Ping An Bank Co Ltd, Shanghai Branch and Shanghai Pudong Development Bank Co Ltd as joint lead arrangers on a US$1.1 billion loan for the take-private of leading plasma-based biopharmaceutical company China Biologic Products Holdings Inc (CBPO).

The loan was made to part finance the US$4.76 billion privatisation, which was completed by way of a Cayman Islands statutory merger between the buyer consortium’s bidco entity, CBPO Group Limited, and CBPO, with CBPO as the surviving entity. 

The buyer consortium comprises Centurium Capital, CITIC Capital, Mr Marc Chan, Hillhouse Capital, Temasek Holdings, and Mr Joseph Chow, CEO and chairman of the board of directors of CBPO and their respective affiliates. CBPO previously traded on NASDAQ and its shares are now suspended, pending their delisting.

The Ogier team was led by banking partner David Nelson (Picture) with support from associate Sara Law.


Involved fees earner: Sara Law – Ogier LLP; David Nelson – Ogier LLP;

Law Firms: Ogier LLP;

Clients: Ping An Bank Co Ltd, Shanghai Branch; Shanghai Pudong Development Bank;

Author: Sonia Carcano